Ccr2 deficiency impairs microglial accumulation and accelerates progression of Alzheimer-like disease
The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Abstract
Microglia are the principal immune cells of the brain. In Alzheimer disease, these brain mononuclear phagocytes are recruited from the blood and accumulate in senile plaques. However, the role of microglia in Alzheimer disease has not been resolved. Microglia may be neuroprotective by phagocytosing amyloid-beta (Abeta), but their activation and the secretion of neurotoxins may also cause neurodegeneration. Ccr2 is a chemokine receptor expressed on microglia, which mediates the accumulation of mononuclear phagocytes at sites of inflammation. Here we show that Ccr2 deficiency accelerates early disease progression and markedly impairs microglial accumulation in a transgenic mouse model of Alzheimer disease (Tg2576). Alzheimer disease mice deficient in Ccr2 accumulated Abeta earlier and died prematurely, in a manner that correlated with Ccr2 gene dosage, indicating that absence of early microglial accumulation leads to decreased Abeta clearance and increased mortality. Thus, Ccr2-dependent microglial accumulation plays a protective role in the early stages of Alzheimer disease by promoting Abeta clearance.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The protective function of Ly6Clo monocytes in AD may also explain why CCR2 deficiency exacerbates disease severity [89, 238]”
From Microglia and monocytes in inflammatory CNS disease: integrating phenotype and function (2022) · cites this paper as [89]
In the citing paper
“CCR2 deficiency worsened AD pathology [89, 238]”
From Microglia and monocytes in inflammatory CNS disease: integrating phenotype and function (2022) · cites this paper as [89]
In the citing paper
“studies utilizing whole body irradiation chimeras, an experimental technique that is now recognized to condition the brain for monocyte infiltration [2, 3, 230], as well as transplant of BM-derived cells, reported that Ly6Chi monocytes infiltrate the AD mouse brain and accumulate around Aβ plaques.”
From Microglia and monocytes in inflammatory CNS disease: integrating phenotype and function (2022) · cites this paper as [89]
In the citing paper
“These infiltrating cells were thought to ameliorate disease evolution by phagocytosis and clearance of Aβ from the brain parenchyma [287] or by promotion of CCR2-mediated microglial accumulation in amyloid plaques and degradation of Aβ [89].”
From Microglia and monocytes in inflammatory CNS disease: integrating phenotype and function (2022) · cites this paper as [89]
In the citing paper
“Marrow-derived cells may have an ameliorative effect on neurodegenerative phenotypes in mice33,34, possibly due to their superior phagocytic capacity35.”
From Clonal hematopoiesis is associated with protection from Alzheimer’s disease (2023) · cites this paper as [34]
13 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Walsh, D. M., Klyubin, I., Fadeeva, J. V., Cullen, W. K., Anwyl, R., Wolfe, M. S., Rowan, M. J., & Selkoe, D. J. (2002) · Nature · doi:10.1038/416535a · Cited by 4,291
Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic Mice
Hsiao, K., Chapman, P., Nilsen, S., Eckman, C., Harigaya, Y., Younkin, S., Yang, F., & Cole, G. (1996) · Science · doi:10.1126/science.274.5284.99 · Cited by 4,210
Chemokines — Chemotactic Cytokines That Mediate Inflammation
Luster, A. D. (1998) · New England Journal of Medicine · doi:10.1056/nejm199802123380706 · Cited by 3,630
Self-citationThe many roles of chemokines and chemokine receptors in inflammation
Charo, I. F., & Ransohoff, R. M. (2006) · New England Journal of Medicine · doi:10.1056/nejmra052723 · Cited by 2,523 · cited 1×
“Chemokines are chemotactic cytokines that bind specific G protein–coupled receptors on the surface of cells and mediate the accumulation of leukocytes at sites of inflammatio”
BackgroundBard, F., Cannon, C., Barbour, R., Burke, R.-L., Games, D., Grajeda, H., Guido, T., Hu, K., Huang, J., Johnson-Wood, K., et al. (2000) · Nature Medicine · doi:10.1038/78682 · Cited by 2,012
RAGE and amyloid-β peptide neurotoxicity in Alzheimer's disease
Yan, S. D., Chen, X., Fu, J., Chen, M., Zhu, H., Roher, A., Slattery, T., Zhao, L., Nagashima, M., Morser, J., et al. (1996) · Nature · doi:10.1038/382685a0 · Cited by 2,012
Simard, A. R., Soulet, D., Gowing, G., Julien, J.-P., & Rivest, S. (2006) · Neuron · doi:10.1016/j.neuron.2006.01.022 · Cited by 1,265
Boring, L., Gosling, J., Chensue, S. W., Kunkel, S. L., Farese, R. V., Broxmeyer, H. E., & Charo, I. F. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119798 · Cited by 1,096
Metabolic Regulation of Brain Aβ by Neprilysin
Iwata, N., Tsubuki, S., Takaki, Y., Shirotani, K., Lu, B., Gerard, N. P., Gerard, C., Hama, E., Lee, H.-J., & Saido, T. C. (2001) · Science · doi:10.1126/science.1059946 · Cited by 961
Adult mouse astrocytes degrade amyloid-β in vitro and in situ
Wyss-Coray, T., Loike, J. D., Brionne, T. C., Lu, E., Anankov, R., Yan, F., Silverstein, S. C., & Husemann, J. (2003) · Nature Medicine · doi:10.1038/nm838 · Cited by 909
Cited by
Items 601–700 of 940
Xia, Z., Peng, W., Cheng, S., Zhong, B., Sheng, C., Zhang, C., Gong, W., Cheng, S., Li, J., & Wang, Z. (2017) · Oncotarget · doi:10.18632/oncotarget.17337 · Cited by 24
Immune Modulation in Alzheimer’s Disease: From Pathogenesis to Immunotherapy
Balkhi, S., Spirito, A. D., Poggi, A. D., & Mortara, L. (2025) · Cells · doi:10.3390/cells14040264 · Cited by 23
Wang, R., Zhou, Z., Wang, D., Zhao, Q., Zhang, C., Liu, C., Zhao, H., Yuan, C., Yuan, D., & Wang, T. (2021) · Food & Function · doi:10.1039/d0fo02946g · Cited by 22
Shiraishi, W., Yamasaki, R., Hashimoto, Y., Ko, S., Kobayakawa, Y., Isobe, N., Matsushita, T., & Kira, J. (2021) · Scientific Reports · doi:10.1038/s41598-021-96064-6 · Cited by 22
Lau, S., Fu, A. K. Y., & Ip, N. Y. (2023) · Journal of Neurochemistry · doi:10.1111/jnc.15933 · Cited by 24
Research Progress on the Pathogenesis, Diagnosis, and Drug Therapy of Alzheimer’s Disease
Yang, Y., & Qiu, L. (2024) · Brain Sciences · doi:10.3390/brainsci14060590 · Cited by 23
Chemokines in neurodegenerative diseases
Vida, H., Sahar, M., Nikdouz, A., & Hosseini, A. (2024) · Immunology and Cell Biology · doi:10.1111/imcb.12843 · Cited by 24
Targeting the hematopoietic system for the treatment of Alzheimer’s disease
Lampron, A., Gosselin, D., & Rivest, S. (2010) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2010.12.018 · Cited by 22
Allen, A. R., Eilertson, K. E., Sharma, S., Schneider, D., Baure, J., Allen, B. D., Rosi, S., Raber, J., & Fike, J. R. (2013) · Radiation Research · doi:10.1667/rr3344.1 · Cited by 23
Rosa, L., Scaini, G., Furlanetto, C. B., Galant, L. S., Vuolo, F. S., Dall’Igna, D. M., Schuck, P. F., Ferreira, G. C., Dal‐Pizzol, F., & STRECK, E. L. (2015) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2015.11.002 · Cited by 24
Chapter 14 Advances in the Discovery of CC Chemokine Receptor 2 Antagonists
Carter, P. H., Cherney, R. J., & Mangion, I. K. (2007) · Annual reports in medicinal chemistry · doi:10.1016/s0065-7743(07)42014-0 · Cited by 23
A beneficial role for IL-1β in Alzheimer disease?
Lemere, C. A. (2007) · Journal of Clinical Investigation · doi:10.1172/jci32356 · Cited by 25
Brain Damage - Bridging Between Basic Research and Clinics
González-Quevedo, A. (2012) · InTech eBooks · doi:10.5772/2174 · Cited by 22
The Chemokine (C-C Motif) Ligand 2 in Neuroinflammation and Neurodegeneration
Madrigal, J. L. M., & Caso, J. R. (2014) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-07320-0_15 · Cited by 22
Hohsfield, L. A., & Humpel, C. (2015) · PLoS ONE · doi:10.1371/journal.pone.0121930 · Cited by 23
Mollica, A., Stefanucci, A., Costante, R., & Pinnen, F. (2012) · Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry · doi:10.2174/187152312803476246 · Cited by 22
Functional inhibition of chemokine receptor CCR2 by dicer-substrate-siRNA prevents pain development
Bégin-Lavallée, V., Midavaine, É., Dansereau, M., Tétreault, P., Longpré, J., Jacobi, A. M., Rose, S. D., Behlke, M. A., Beaudet, N., & Sarret, P. (2016) · Molecular Pain · doi:10.1177/1744806916653969 · Cited by 21
Rao, S., Ghani, M., Guo, Z., Deming, Y. K., Wang, K., Sims, R., Mao, C., Yao, Y., Cruchaga, C., Stephan, D. A., et al. (2018) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2017.12.027 · Cited by 24
Al‐Onaizi, M., Thériault, P., Lecordier, S., Préfontaine, P., Rivest, S., & ElAli, A. (2021) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2021.07.016 · Cited by 20
Identification of Biomarkers Related to M2 Macrophage Infiltration in Alzheimer’s Disease
Lin, C., Xu, C., Zhou, Y., Chen, A., & Jin, B. (2022) · Cells · doi:10.3390/cells11152365 · Cited by 24
Hu, H., Xue, Y., He, Y., Duan, C., & Sun, N. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-022-02569-w · Cited by 23
Beltran-Lobo, P., Hughes, M. M., Troakes, C., Croft, C. L., Rupawala, H., Jutzi, D., Ruepp, M., Jiménez-Sánchez, M., Perkinton, M. S., Kassiou, M., et al. (2023) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2023.09.011 · Cited by 24
Schütze, S., Loleit, T., Zeretzke, M., Bunkowski, S., Brück, W., Ribes, S., & Nau, R. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-120856 · Cited by 27
Speidel, A., Felk, S., Reinhardt, P., Sterneckert, J. L., & Gillardon, F. (2016) · PLoS ONE · doi:10.1371/journal.pone.0165949 · Cited by 22
Oligomeric Forms of Human Amyloid-Beta(1–42) Inhibit Antigen Presentation
Gericke, C., Mallone, A., Engelhardt, B., Nitsch, R. M., & Ferretti, M. T. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01029 · Cited by 22
Aguilar, L. F., Iulita, M. F., Orciani, C., Tanna, N., Yang, J., Bennett, D. A., & Cuello, A. C. (2021) · Journal of Neuroinflammation · doi:10.1186/s12974-021-02169-0 · Cited by 27
Kiyota, T., Morrison, C. M., Tu, G., Dyavarshetty, B., Weir, R. A., Zhang, G., Xiong, H., & Gendelman, H. E. (2015) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2015.06.014 · Cited by 20
Kirshner, M., Galron, R., Frenkel, D., Mandelbaum, G., Shiloh, Y., Wang, Z., & Barzilai, A. (2011) · Journal of Molecular Neuroscience · doi:10.1007/s12031-011-9643-y · Cited by 20
The Dual Nature of Microglia in Alzheimer’s Disease: A Microglia-Neuron Crosstalk Perspective
Xie, Z., Meng, J., Wu, Z., Nakanishi, H., Hayashi, Y., Kong, W., Lan, F., Narengaowa, Yang, Q., Qing, H., et al. (2023) · The Neuroscientist · doi:10.1177/10738584211070273 · Cited by 19
Hongisto, H., Dewing, J. M., Christensen, D. R., Scott, J., Cree, A. J., Nättinen, J. E., Määttä, J. A. E., Jylhä, A., Aapola, U., Uusitalo, H. M. T., et al. (2020) · The Journal of Pathology · doi:10.1002/path.5506 · Cited by 18
Olfactory Evaluation in Alzheimer’s Disease Model Mice
Zhang, J., Zhao, Z., Sun, S., Li, J., Wang, Y., Dong, J., Yang, S. C., Lou, Y., Yang, J., Li, W., et al. (2022) · Brain Sciences · doi:10.3390/brainsci12050607 · Cited by 19
The Immune System as a Therapeutic Target for Alzheimer’s Disease
Zieneldien, T., Kim, J., Sawmiller, D. R., & Cao, C. (2022) · Life · doi:10.3390/life12091440 · Cited by 24
Myeloid cell subpopulations compensate each other for Ccr2‐deficiency in glioblastoma
Bungert, A. D., Urbantat, R. M., Jelgersma, C., Bekele, B. M., Mueller, S. G., Mueller, A., Felsenstein, M., Dusatko, S., Blank, A., Ghori, A., et al. (2022) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12863 · Cited by 19
Chemokines in patients with Alzheimer's disease: A meta-analysis
Wang, H., Zong, Y., Zhu, L., Wang, W., & Han, Y. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1047810 · Cited by 21
Krix, S., Wilczynski, E., Falgàs, N., Sánchez‐Valle, R., Yoles, E., Nevo, U., Baruch, K., & Fröhlich, H. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1343900 · Cited by 23
Ovsepian, S. V., & Herms, J. W. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.05.005 · Cited by 21
Khorshid, H. R. K., Manoochehri, M., Nasehi, L., Ohadi, M., Rahgozar, M., & Kamali, K. (2012) · PubMed Central · Cited by 22
Tsay, H.-J., Liu, H., Kuo, Y., Chiu, C.-S., Liang, C.-C., Chung, C.-W., Chen, C., Chen, Y.-P., & Shiao, Y. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910413 · Cited by 20
Leveraging gene co-regulation to identify gene sets enriched for disease heritability
Siewert, K. M., Kim, S. S., Yao, D. W., Shi, H., & Price, A. L. (2022) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2022.01.005 · Cited by 21
Rahgozar, K., Wright, E., Carrithers, L. M., & Carrithers, M. D. (2013) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e318293eb08 · Cited by 20
Park, S. M., Shin, J. H., Moon, G. J., Cho, S. I., Lee, Y. B., & Gwag, B. J. (2011) · BMC Neuroscience · doi:10.1186/1471-2202-12-106 · Cited by 22
Assessing Neuroprotective Agents for Aβ-Induced Neurotoxicity
Forest, K. H., & Nichols, R. A. (2019) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2019.05.013 · Cited by 19
Role of Infiltrating Microglia/Macrophages in Glioma
Catalano, M., D’Alessandro, G., Trettel, F., & Limatola, C. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-30651-9_14 · Cited by 21
An overview on microglial origin, distribution, and phenotype in Alzheimer's disease
Islam, R., Choudhary, H. H., Rajan, R. G., Vrionis, F. D., & Hanafy, K. A. (2022) · Journal of Cellular Physiology · doi:10.1002/jcp.30829 · Cited by 20
Interferons: A molecular switch between damage and repair in ageing and Alzheimer’s disease
Gorlé, N., & Vandenbroucke, R. E. (2019) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2019.111148 · Cited by 22
Microglial Potassium Channels: From Homeostasis to Neurodegeneration
Cocozza, G., Garofalo, S., Capitani, R., D’Alessandro, G., & Limatola, C. (2021) · Biomolecules · doi:10.3390/biom11121774 · Cited by 20
Enlargement of Aβ aggregates through chemokine-dependent microglial clustering
Huang, W.-C., Yen, F.-C., Shiao, Y., Shie, F., Chan, J.-L., Yang, C.-N., Sung, Y.-J., Huang, F.-L., & Tsay, H.-J. (2009) · Neuroscience Research · doi:10.1016/j.neures.2009.01.001 · Cited by 18
Li, C., Chen, Y.-H., & Zhang, K. (2020) · American Journal of Alzheimer's Disease & Other Dementias® · doi:10.1177/1533317520927169 · Cited by 17
Music compensates for altered gene expression in age-related cognitive disorders
Gómez‐Carballa, A., Navarro, L., Pardo‐Seco, J., Bello, X., Pischedda, S., Viz-Lasheras, S., Camino‐Mera, A., Currás-Tuala, M. J., Ferreirós-Vidal, I., Mallah, N., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-48094-5 · Cited by 23
Galron, R., Gruber, R., Lifshitz, V., Lu, H., Kirshner, M., Ziv, N., Wang, Z., Shiloh, Y., Barzilai, A., & Frenkel, D. (2011) · Journal of Molecular Neuroscience · doi:10.1007/s12031-011-9494-6 · Cited by 17
Genomics and Successful Aging: Grounds for Renewed Optimism?
Pilling, L. C., Harries, L. W., Powell, J. E., Llewellyn, D. J., Ferrucci, L., & Melzer, D. R. (2012) · The Journals of Gerontology Series A · doi:10.1093/gerona/gls091 · Cited by 20
PET Imaging Radiotracers of Chemokine Receptors
Alluri, S. R., Higashi, Y., & Kil, K.-E. (2021) · Molecules · doi:10.3390/molecules26175174 · Cited by 18
Borgonetti, V., Coppi, E., & Galeotti, N. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910394 · Cited by 18
Oligomeric amyloid-β(1–42) induces THP-1 human monocyte adhesion and maturation
Crouse, N. R., Ajit, D., Udan, M. L. D., & Nichols, M. R. (2008) · Brain Research · doi:10.1016/j.brainres.2008.11.093 · Cited by 20
Quarta, A., Berneman, Z. N., & Ponsaerts, P. (2020) · Journal of Leukocyte Biology · doi:10.1002/jlb.3ru0820-536r · Cited by 17
Ball, B. K., Kuhn, M. K., Fleeman, R. M., Proctor, E. A., & Brubaker, D. K. (2024) · Scientific Reports · doi:10.1038/s41598-024-62155-3 · Cited by 17
The intricate interplay between microglia and adult neurogenesis in Alzheimer’s disease
Früholz, I., & Meyer‐Luehmann, M. (2024) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2024.1456253 · Cited by 18
CCR2 overexpression promotes the efficient recruitment of retinal microglia in vitro.
Jiang, X., Ni, Y., Liu, T., Zhang, M., Ren, H., Jiang, R., Huang, X., & Xu, G. (2012) · PubMed Central · Cited by 21
François, A., Julian, A., Ragot, S., Dugast, E., Blanchard, L., Brishoual, S., Chassaing, D., Page, G., & Paccalin, M. (2015) · PLoS ONE · doi:10.1371/journal.pone.0138326 · Cited by 17
Muramyl Dipeptide Administration Delays Alzheimer’s Disease Physiopathology via NOD2 Receptors
Piec, P.-A., Pons, V., Préfontaine, P., & Rivest, S. (2022) · Cells · doi:10.3390/cells11142241 · Cited by 17
Key brain cell interactions and contributions to the pathogenesis of Alzheimer’s disease
Saavedra, J., Nascimento, M., Liz, M. A., & Cardoso, I. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.1036123 · Cited by 16
Inflammatory Chemokines Expression Variations and Their Receptors in APP/PS1 Mice
Jorda, A., Aldasoro, M., Aldasoro, C., & Vallés, S. L. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-210489 · Cited by 16
Deleterious effect of sustained neuroinflammation in pediatric traumatic brain injury
Jacquens, A., Csaba, Z., Soleimanzad, H., Bokobza, C., Delmotte, P.-R., Userovici, C., Boussemart, P., Chhor, V., Bouvier, D., van de Looij, Y., et al. (2024) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2024.04.029 · Cited by 16
Lorenzini, L., Zanella, L., Sannia, M., Baldassarro, V. A., Moretti, M., Cescatti, M., Quadalti, C., Baldi, S., Bartolucci, G., Gloria, L. D., et al. (2024) · Alzheimer s Research & Therapy · doi:10.1186/s13195-024-01471-2 · Cited by 16
Yu, H., Shen, B., Han, R., Zhang, Y., Xu, S., Zhang, Y., Guo, Y., Huang, P., Huang, S., & Zhong, Y. (2024) · Inflammation and Regeneration · doi:10.1186/s41232-024-00343-4 · Cited by 16
Guo, D., Zhu, W., & Qiu, H. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25168794 · Cited by 19
Monocyte Invasion into the Retina Restricts the Regeneration of Neurons from Müller Glia
Blasdel, N., Bhattacharya, S., Donaldson, P. C., Reh, T. A., & Todd, L. J. (2024) · Journal of Neuroscience · doi:10.1523/jneurosci.0938-24.2024 · Cited by 15
Microglial Modulation in Alzheimer’s Disease: Central Players in Neuroinflammation and Pathogenesis
Hussain, M. S., Khan, Y., Fatima, R., Maqbool, M., Ramalingam, P. S., Khan, M. G., & Bisht, A. S. (2025) · Current Alzheimer Research · doi:10.2174/0115672050364292250113063513 · Cited by 18
Taipa, R. J. F., Sousa, A. L., Pires, M. M., & Sousa, N. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160121 · Cited by 16
Targeting prion proteins in neurodegenerative disease
Gilch, S., Nussbaum-Krammer, C. I., & Schätzl, H. M. (2008) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.8.7.923 · Cited by 18
Psychotropic Drug Effects on Gene Transcriptomics Relevant to Alzheimer Disease
Lauterbach, E. C. (2011) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0b013e318214b7d0 · Cited by 16
Richman, M., Perelman, A., Gertler, A. A., & Rahimipour, S. (2012) · Biomacromolecules · doi:10.1021/bm301401b · Cited by 15
AD Vaccines: Conclusions and Future Directions
Wisniewski, T. (2009) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152709787847289 · Cited by 14
“A number of recent studies suggest that only a small percentage of plaques are associated with peripheral origin macrophages and that these are required for plaque clearance [44-46], Vaccination approaches based on this knowledge are now being developed.”
BackgroundNeuroinflammation and Disease: Pathways and Opportunities
Hoffman, O., Varvel, N. H., Roopra, A., & Dingledine, R. J. (2025) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-062124-043519 · Cited by 15
Monoranu, C.-M., Hartmann, T., Strobel, S., Heinsen, H., Riederer, P., Distel, L. V., & Bohnert, S. (2021) · Journal of Alzheimer s Disease Reports · doi:10.3233/adr-210052 · Cited by 15
Yuan, D., Huang, B., Gu, M., Qin, B., Su, Z., Dai, K., Peng, F., & Jiang, Y. (2023) · European Neurology · doi:10.1159/000533397 · Cited by 14
CCR2+ monocytes promote white matter injury and cognitive dysfunction after myocardial infarction
Thorp, E. B., Filipp, M. E., Dima, M., Tan, C., Feinstein, M. J., Popko, B., & DeBerge, M. (2024) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2024.05.004 · Cited by 18
The generation of NGF-secreting primary rat monocytes: A comparison of different transfer methods
Hohsfield, L. A., Geley, S., Reindl, M., & Humpel, C. (2013) · Journal of Immunological Methods · doi:10.1016/j.jim.2013.02.016 · Cited by 16
Mir, P. A., Kumar, N. G., Bhutia, G. T., Chaudhary, P., Kaur, G., & Gupta, S. K. (2026) · GeroScience · doi:10.1007/s11357-025-02062-1 · Cited by 14
Modulation of Monocyte Effector Functions and Gene Expression by Human Cytomegalovirus Infection
Khoury, J. B. E., Fishman, J. A., & Planchon, M. S. (2024) · Viruses · doi:10.3390/v16121809 · Cited by 15
Adaptive immunity in the neuroinflammation of Alzheimer’s disease
Liu, H., Chen, Y., Zhang, J., & Chen, X. (2025) · Chinese Medical Journal · doi:10.1097/cm9.0000000000003695 · Cited by 15
Kozyrev, N., Albers, S. S., Yang, J., Prado, V. F., Prado, M. A. M., Fonseca, G. J., Rylett, R. J., & Dekaban, G. A. (2020) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlaa093 · Cited by 14
Mitochonic acid 5 regulates mitofusin 2 to protect microglia
Tan, J., Chen, S., Lei, Q., Yi, S., Wu, N., Wang, Y., Xiao, Z., & Wu, H. (2021) · Neural Regeneration Research · doi:10.4103/1673-5374.306094 · Cited by 13
CCL2 Inhibition of Pro-Resolving Mediators Potentiates Neuroinflammation in Astrocytes
Gutiérrez, I. L., Novellino, F., Caso, J. R., García‐Bueno, B., Leza, J. C., & Madrigal, J. L. M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23063307 · Cited by 14
The vicious cycle governing the brain–immune system relationship in neurodegenerative diseases
Schwartz, M., & Cahalon, L. (2022) · Current Opinion in Immunology · doi:10.1016/j.coi.2022.102182 · Cited by 14
The interplay between monocytes, α-synuclein and LRRK2 in Parkinson's disease
Strader, S., & West, A. B. (2023) · Biochemical Society Transactions · doi:10.1042/bst20201091 · Cited by 14
Wang, S., Liu, Y., Li, X., Algradi, A. M., Jiang, H., Sun, Y., Guan, W., Pan, J., Kuang, H., & Yang, B. (2021) · Molecules · doi:10.3390/molecules26195946 · Cited by 15
MCP-1 levels in astrocyte-derived exosomes are changed in preclinical stage of Alzheimer's disease
Wang, T., Yao, Y., Han, C., Li, T., Du, W., Xue, J., Han, Y., & Cai, Y. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1119298 · Cited by 15
Ai, S., Arutyunov, A., Liu, J., Hill, J. D., Jiang, X., & Klein, R. S. (2024) · Journal of Neuroinflammation · doi:10.1186/s12974-024-03309-y · Cited by 12
Expanding horizons in theragnostics: from oncology to multidisciplinary applications
Wu, R., Zhu, W., Shao, F., Wang, J. Z., Li, D., Tuo, Z., Yoo, K. H., Wusiman, D., Shu, Z., Ge, W., et al. (2025) · La radiologia medica · doi:10.1007/s11547-025-01971-7 · Cited by 12
Advances in proteomic phenotyping of microglia in neurodegeneration
Sunna, S. N., Bowen, C. A., Ramelow, C. C., Santiago, J. V., Kumar, P., & Rangaraju, S. (2023) · PROTEOMICS · doi:10.1002/pmic.202200183 · Cited by 13
Khan, R. I., Nirzhor, S. S. R., & Rashid, B. (2018) · Brain Sciences · doi:10.3390/brainsci8090162 · Cited by 13
Immunomodulation by poly-YE reduces organophosphate-induced brain damage
Finkelstein, A., Kunis, G., Berkutzki, T., Ronen, A., Krivoy, A., Yoles, E., Last, D., Mardor, Y., Shura, K. E. V., McFarland, E., et al. (2011) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2011.09.002 · Cited by 13
Barzilai, A. (2013) · DNA repair · doi:10.1016/j.dnarep.2013.04.007 · Cited by 11
Natural Product Co-Metabolism and the Microbiota–Gut–Brain Axis in Age-Related Diseases
Obrenovich, M. E., Singh, S. K., Li, Y., Perry, G. L., Siddiqui, B., Haq, W., & Reddy, V. P. (2022) · Life · doi:10.3390/life13010041 · Cited by 11
Drummond, E., Muhling, J., Martins, R. N., Wijaya, L. K., Ehlert, E., & Harvey, A. R. (2013) · PLoS ONE · doi:10.1371/journal.pone.0059166 · Cited by 11
Sui, Y., Zhang, Y., Dong, C., Xu, B., & Sun, X. (2019) · Brain Research · doi:10.1016/j.brainres.2019.05.022 · Cited by 12
Connectome-based biophysics models of Alzheimer’s disease diagnosis and prognosis
Torok, J., Anand, C., Verma, P., & Raj, A. (2022) · Translational research · doi:10.1016/j.trsl.2022.08.008 · Cited by 14
Chlan‐Fourney, J., Zhao, T., Walz, W., & Mousseau, D. D. (2011) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2010.07597.x · Cited by 11
The Orphan C2orf40 Gene is a Neuroimmune Factor in Alzheimer's Disease.
Podvin, S., Miller, M. C., Rossi, R., Chukwueke, J., Donahue, J. E., Johanson, C. E., Baird, A., & Stopa, E. G. (2016) · PubMed · Cited by 14
Metadata
- Authors
- El Khoury, J., Toft, M., Hickman, S. E., Means, T. K., Terada, K., Geula, C., & Luster, A. D.
- Affiliations
- Okayama University (JP)
- Northwestern University (US)
- Corresponding author
- Luster, Andrew D
- Venue
- Nature Medicine
- Published
- 2007-03-11
- Volume
- 13
- Issue
- 4
- Pages
- 432-438
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W2097867538
- Cited by
- 915
- References
- 51
- Citations by year
- 2026: 29 · 2025: 27 · 2024: 41 · 2023: 35 · 2022: 44 · 2021: 70 · 2020: 51 · 2019: 37 · 2018: 42 · 2017: 51 · 2016: 51 · 2015: 60 · 2014: 43 · 2013: 53 · 2012: 70
- FWCI
- 34.66
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- American Health Assistance Foundation
- Dana Foundation
- Gladstone Institutes
- National Institutes of Health
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
- Keywords
- CCR2, chemokine receptors, microglia, Alzheimer's disease, amyloid-beta clearance, Tg2576 mice, disease progression, neuroinflammation, gene dosage, neuroprotection
- MeSH terms
- Alzheimer Disease, Analysis of Variance, Animals, Brain, Crosses, Genetic, Enzyme-Linked Immunosorbent Assay, Flow Cytometry, Immunohistochemistry, Monocytes, Amyloid beta-Peptides, Microglia, Mice, Knockout, Models, Immunological, Chemokines, Mice, Receptors, CCR2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.